Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant

Transplantation Proceedings

Volumn 38, Issue 1, 2006, Pages 56-58

  Wisniewski A ^a   Kusztal, M ^b   Magott Procelewska, M ^b   Klinger, M ^b   Jasek, M ^a   Luszczek W ^a   Nowak, I ^a   Kosmaczewska, A ^a   Ciszak, L ^a   Frydecka, I ^a   Gorski A ^a   Kusnierczyk P ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ACUTE GRAFT REJECTION; ALLELE; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ACUTE DISEASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; GENE FREQUENCY; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSPLANTATION, HOMOLOGOUS;

EID: 33644547679     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.094     Document Type: Conference Paper

References (17)

1. O.P. Kristiansen, Z.M. Larsen, F. Pociot CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1 2000 170
2. H. Ueda, J.M.M. Howson, L. Esposito Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506
3. E. Slavcheva, E. Albanis, Q. Jiao Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection Transplantation 72 2001 935
4. P. de Reuver, V. Pravica, W. Hop Recipient CTLA-4 +49G/G genotype is associated with reduced incidence of acute rejection after liver transplantation Am J Transplant 3 2003 1587
5. C.I. Kingsley, M. Karim, A.R. Bushell CD25+CD4+ regulatory T cells prevent graft rejection CTLA-4- and IL-10-dependent immunoregulation of alloresponses J Immunol 168 2002 1080
6. E. Elster, D.A. Hale, R.B. Mannon The road to tolerance renal transplant tolerance induction in nonhuman primate studies and clinical trials Transplant Immunol 13 2004 87
7. J. Strehlau, M. Pavlakis, M. Lipman The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation Clin Nephrol 46 1996 30
8. T. Kouki, Y. Sawai, C.A. Gardine CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease J Immunol 165 2000 6606
9. M. Maurer, S. Loserth, A. Kolb-Maurer A polymorphism in the human cytotoxic T-lymphocyte antigen 4 gene (exon 1 +49) alters T-cell activation Immunogenetics 54 2002 1
10. S. Anjos, A. Nguyen, H. Ounissi-Benkalha A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele J Biol Chem 277 2002 46478
11. H.F. Harbo, E.G. Celius, F. Vartdal CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis Tissue Antigens 53 1999 106
12. T.D. Howard, D.S. Postma, G.A. Hawkins Fine mapping of an IgE-controlling gene on chromosome 2q analysis of CTLA4 and CD28 J Allergy Clin Immunol 110 2002 743
13. X.B. Wang, X. Zhao, R. Giscombe A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein Genes Immun 3 2002 233
14. A. Ligers, N. Teleshova, T. Masterman CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2 2001 145
15. B. Marder, B. Schroppel, M. Lin The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation Am J Transplant 3 2003 424
16. P.M. Holopainen, J.A. Partanen Technical note linkage disequilibrium and disease-associated CTLA4 gene polymorphisms J Immunol 167 2001 2457
17. R. Cortesini, N. Suciu-Foca The concept of "partial" clinical tolerance Transplant Immunol 3 2004 101